These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34794767)

  • 1. Urinary [TIMP-2]·[IGFBP7]-guided implementation of the KDIGO bundle to prevent acute kidney injury: a meta-analysis.
    Li Z; Tie H; Shi R; Rossaint J; Zarbock A
    Br J Anaesth; 2022 Jan; 128(1):e24-e26. PubMed ID: 34794767
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial.
    Meersch M; Schmidt C; Hoffmeier A; Van Aken H; Wempe C; Gerss J; Zarbock A
    Intensive Care Med; 2017 Nov; 43(11):1551-1561. PubMed ID: 28110412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary [TIMP-2]·[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department.
    Schanz M; Wasser C; Allgaeuer S; Schricker S; Dippon J; Alscher MD; Kimmel M
    Nephrol Dial Transplant; 2019 Nov; 34(11):1902-1909. PubMed ID: 29961888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Cardiac Surgery-Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial.
    Zarbock A; Küllmar M; Ostermann M; Lucchese G; Baig K; Cennamo A; Rajani R; McCorkell S; Arndt C; Wulf H; Irqsusi M; Monaco F; Di Prima AL; García Alvarez M; Italiano S; Miralles Bagan J; Kunst G; Nair S; L'Acqua C; Hoste E; Vandenberghe W; Honore PM; Kellum JA; Forni LG; Grieshaber P; Massoth C; Weiss R; Gerss J; Wempe C; Meersch M
    Anesth Analg; 2021 Aug; 133(2):292-302. PubMed ID: 33684086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest.
    Cummings JJ; Shaw AD; Shi J; Lopez MG; O'Neal JB; Billings FT
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1545-1553.e5. PubMed ID: 30389130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker-guided intervention to prevent acute kidney injury after major surgery (BigpAK-2 trial): study protocol for an international, prospective, randomised controlled multicentre trial.
    von Groote T; Meersch M; Romagnoli S; Ostermann M; Ripollés-Melchor J; Schneider AG; Vandenberghe W; Monard C; De Rosa S; Cattin L; Rahmel T; Adamzik M; Parise D; Candela-Toha A; Haaker JG; Göbel U; Bernard A; Lumlertgul N; Fernández-Valdes-Bango P; Romero Bhathal I; Suarez-de-la-Rica A; Larmann J; Villa G; Spadaro S; Wulf H; Arndt C; Putensen C; García-Álvarez R; Brandenburger T; Siniscalchi A; Ellerkmann R; Espeter F; Porschen C; Sadjadi M; Saadat-Gilani K; Weiss R; Gerss J; Kellum J; Zarbock A;
    BMJ Open; 2023 Mar; 13(3):e070240. PubMed ID: 36972972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of acute kidney injury and the role of urinary [TIMP-2]·[IGFBP7]: a prospective cohort study in critically ill obstetric patients.
    Tyagi A; Luthra A; Kumar M; Das S
    Int J Obstet Anesth; 2018 Nov; 36():77-84. PubMed ID: 30245258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic accuracy of urinary [TIMP-2]·[IGFBP7] for acute kidney injury in adults: A PRISMA-compliant meta-analysis.
    Liu C; Lu X; Mao Z; Kang H; Liu H; Pan L; Hu J; Wang L; Zhou F
    Medicine (Baltimore); 2017 Jul; 96(27):e7484. PubMed ID: 28682920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study.
    Liu KD; Vijayan A; Rosner MH; Shi J; Chawla LS; Kellum JA
    Nephrol Dial Transplant; 2016 Oct; 31(10):1641-6. PubMed ID: 27342580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery: The Prospective Randomized BigpAK Study.
    Göcze I; Jauch D; Götz M; Kennedy P; Jung B; Zeman F; Gnewuch C; Graf BM; Gnann W; Banas B; Bein T; Schlitt HJ; Bergler T
    Ann Surg; 2018 Jun; 267(6):1013-1020. PubMed ID: 28857811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers.
    Dusse F; Edayadiyil-Dudásova M; Thielmann M; Wendt D; Kahlert P; Demircioglu E; Jakob H; Schaefer ST; Pilarczyk K
    BMC Anesthesiol; 2016 Sep; 16():76. PubMed ID: 27609347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (TIMP2) x (IGFBP7) as early renal biomarker for the prediction of acute kidney injury in aortic surgery (TIGER). A single center observational study.
    Waskowski J; Pfortmueller CA; Schenk N; Buehlmann R; Schmidli J; Erdoes G; Schefold JC
    PLoS One; 2021; 16(1):e0244658. PubMed ID: 33411755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery.
    Gocze I; Koch M; Renner P; Zeman F; Graf BM; Dahlke MH; Nerlich M; Schlitt HJ; Kellum JA; Bein T
    PLoS One; 2015; 10(3):e0120863. PubMed ID: 25798585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.
    Meersch M; Schmidt C; Van Aken H; Martens S; Rossaint J; Singbartl K; Görlich D; Kellum JA; Zarbock A
    PLoS One; 2014; 9(3):e93460. PubMed ID: 24675717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary [TIMP-2]·[IGFBP7] - Novel Biomarkers to Predict Acute Kidney Injury.
    Kimmel M; Shi J; Wasser C; Biegger D; Alscher MD; Schanz MB
    Am J Nephrol; 2016; 43(5):375-82. PubMed ID: 27174659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urine biomarker panel [IGFBP7]x[TIMP-2] (NephroCheck® parameter) does not correlate with IGFBP7 and TIMP-2 gene expression in urinary sediment.
    Knafl D; Müller M; Pajenda S; Genc Z; Hecking M; Wagner L
    PLoS One; 2017; 12(11):e0188316. PubMed ID: 29145491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary [TIMP-2] × [IGFBP7] for risk prediction of acute kidney injury in decompensated heart failure.
    Schanz M; Shi J; Wasser C; Alscher MD; Kimmel M
    Clin Cardiol; 2017 Jul; 40(7):485-491. PubMed ID: 28295429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference intervals of urinary acute kidney injury (AKI) markers [IGFBP7]∙[TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI.
    Chindarkar NS; Chawla LS; Straseski JA; Jortani SA; Uettwiller-Geiger D; Orr RR; Kellum JA; Fitzgerald RL
    Clin Chim Acta; 2016 Jan; 452():32-7. PubMed ID: 26522657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The urine biomarkers TIMP2 and IGFBP7 can identify patients who will experience severe acute kidney injury following a cardiac arrest: A prospective multicentre study.
    Titeca-Beauport D; Daubin D; Chelly J; Zerbib Y; Brault C; Diouf M; Slama M; Vinsonneau C; Klouche K; Maizel J
    Resuscitation; 2019 Aug; 141():104-110. PubMed ID: 31216431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury.
    Westhoff JH; Tönshoff B; Waldherr S; Pöschl J; Teufel U; Westhoff TH; Fichtner A
    PLoS One; 2015; 10(11):e0143628. PubMed ID: 26606754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.